Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL)

Mantle cell lymphoma (MCL) is a rare B-cell malignancy that remains challenging to treat with high rates of relapse. Frontline strategies range from intensive chemotherapy followed by consolidation with autologous stem cell transplant (ASCT), to less-intensive therapies including combination regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tbakhi, Bushra, Reagan, Patrick M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882938/
https://www.ncbi.nlm.nih.gov/pubmed/35237395
http://dx.doi.org/10.1177/20406207221080738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882938/
https://www.ncbi.nlm.nih.gov/pubmed/35237395
http://dx.doi.org/10.1177/20406207221080738

Ejemplares similares